Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo

Authors: Renfei Du, Ahmed Y. Sanin, Wenjie Shi, Bing Huang, Ann-Christin Nickel, Andres Vargas-Toscano, Shuran Huo, Thomas Nickl-Jockschat, Claudia A. Dumitru, Wei Hu, Siyu Duan, I. Erol Sandalcioglu, Roland S. Croner, Joshua Alcaniz, Wolfgang Walther, Carsten Berndt, Ulf D. Kahlert

Source: Frontiers in Pharmacology, Vol 15 (2024)

Subject Terms: trihexyphenidyl, glioblastoma, mesenchymal transformation, drug repurposing, cystathionine beta-synthase, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1468920/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/6f46caeb3c7e4375a3ce00e72c97f3d4